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Aim of the study: To find differences 
between a group of patients with in­
traocular melanoma and another pri­
mary cancer and a group of patients 
with no identifiable second primary 
cancer.
Material and methods: The analysis in­
volved 240 participants, selected from 
patients who were treated for uveal 
melanoma at the Department of Oph­
thalmology and Ocular Oncology of 
the Jagiellonian University Medical 
College between the year 1998 and 
2007. Among those patients 97 were 
diagnosed with one or more indepen­
dent primary cancers. Those patients 
were subject to a comparative anal­
ysis with a second group of 143 pa­
tients who had uveal melanoma with 
no identifiable second primary cancer.
Results: Statistically significant differ­
ences between the group of patients 
with intraocular melanoma and an­
other primary cancer, and the group 
of patients with uveal melanoma (but 
without another diagnosed primary 
neoplasm) were as follows: more com­
mon family history of cancer, better 
education, living in cities (especially 
with a population over 500 thousand), 
previous surgery except for uveal mela­
noma, and two or less than two preg­
nancies in the case of women.
Conclusions: This analysis revealed 
that more common family history of can­
cer, better education, living in cit ies 
(especially with a population over 500 
thousand), previous surgery, except 
for uveal melanoma, and two or less 
than two pregnancies in the case of 
women, were associated with a high­
er rate of detection of multiple prima­
ry cancers.
Key words: uveal melanoma, multiple 
primary cancers.
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Introduction
Uveal melanoma is the most common primary intraocular cancer in 
adults [1]. The tumor occurs in approximately 4.3–7 cases per million per 
year [2–5] and comprises 2.9% of all melanomas [4].
Anomalies in chromosomes 1, 3, 6, 8, 13, 16, 18 in uveal melanoma have 
been described [6, 7]. The most common prognosis-affecting chromosomal 
disorders associated with the tumor include: loss of chromosome 1p, 3, 6q 
and 8p and an extra copy of chromosome 6p and 8q [6–9]. According to 
many authors monosomy 3 is associated with highly aggressive, rapidly pro-
gressive disease [7, 10–14].
There are some other reported cases of primary cancers in patients with 
uveal melanoma, but limited data exist regarding factors causing develop-
ment of another primary cancers among the affected patients.
There are reports on development of other primary cancers of other or-
gans available in the literature [15–17].
The problem of multiple primary cancers emerged as a medical issue al-
ready in the nineteenth century. Renaud in 1847 and Rokitansky in 1855 re-
ported cases of two independent cancers [15].
The aim of the current analysis was to find differences between the group 
of patients with intraocular melanoma and another malignant neoplasm of 
different origin, and another group of patients with uveal melanoma but no 
other diagnosed primary cancer. Primary malignancies included skin can-
cers, colon cancer, skin melanoma, cancers involving the breast and genital 
tract in females and other less common cancers in our analysis.
Material and methods
Two hundred forty patients diagnosed and treated with uveal melanoma at 
the Clinic of Ophthalmology and Ocular Oncology of the Jagiellonian University 
Medical College in Kraków, Poland, from January 1998 to December 2007 were 
included in the analysis. The study group involved 97 patients with other primary 
malignancies; 57 (58.8%) patients were females and 40 (41.2%) were males. The 
patients’ age ranged between 35 and 83, with a mean age of 63.2 ±9.9 (Table 1).
Information about patients’ current health condition and answers to 
questionnaires were obtained from 87 patients (51 women and 36 men) or 
their relatives. In other cases, data were analyzed on the basis of the medical 
history. The above-mentioned group was compared with another group of 
patients with uveal melanoma but without the diagnosis of another primary 
cancer. The control group consisted of 143 patients, 83 (58%) females and 
60 (42%) males, aged 36–87 years, with a mean age of 59.6 ±12.1 (Table 2).
The analysis was based on the clinical examination and data were ob-
tained from patients (or their relatives) during a follow-up.
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An analysis of the influence of factors including marital 
status, education, occupation, place and region of resi-
dence, smoking, alcohol consumption, exposure to sun-
light, exposure to harmful chemicals, hormonal factors 
and a history of pregnancy, a history of surgery for treat-
ment of unbound uveal melanoma and the presence of 
cancer in the family (on the occurrence of multiple primary 
cancers in patients with uveal melanoma) was performed.
Statistical analysis was performed using the χ2 test, lo-
gistic regression and Kaplan-Meier survival curves. Statis-
tical significance was accepted as p < 0.05.
Results
Patients with multiple primary cancers, compared to 
patients without the diagnosis of other primary malignan-
cies, reported more commonly a family history of cancer in 
1st degree relatives (p = 0.0073) and in 1st and/or 2nd degree 
relatives (p = 0.0001) (Figs. 1, 2).
Patients with multiple primary malignancies more often 
had secondary and higher education (p = 0.0001), more of-
ten worked [according to the ISCO-88 (COM) classification] 
as “professionals” (p = 0.0001) [18], were primarily city 
dwellers [as opposed to living in rural areas (p = 0.0060)], 
especially cities with a population over 500 thousand (p = 
= 0.0001) [19], more frequently had a history of surgery 
unrelated to uveal melanoma (p = 0.0000), and – in the 
case of women – had fewer (≤ 2) pregnancies on average 
(p = 0.0008) (Figs. 3 [18], 4, 5 [19], 6, 7).
Logistic regression analysis revealed that the preva-
lence of multiple primary cancers in patients with uveal 
melanoma depended on a few above-mentioned factors: 
secondary and higher education, living in a city with 
a population of over 500 thousand, undergoing surgery, 
and a family history of cancer (in 1st and 1st and/or 2nd de-
gree relatives). Patients’ profession was not taken into 
consideration in logistic regression analysis, because this 
variable was dependent on the education. The number of 
pregnancies was not taken into consideration as well, be-
cause of its limitation to women (Table 3, 4).
The occurrence of other primary cancers among pa-
tients with uveal melanoma was not statistically signifi-
cantly associated with other individually analyzed factors 
listed above.
Discussion
Patients with multiple primary cancers, compared to 
patients without the diagnosis of other primary malig-
nancies, reported more common family history of cancers 
among their relatives.
Abdel-Rahman et al. [20] observed that uveal melano-
ma patients with a family history suggesting a high risk of 
predisposition to a known cancer syndrome were at sig-
nificantly higher risk for having a second cancer, compared 
to the remaining uveal melanoma patients.
Bergman et al. [21] observed an increased risk of second 
primary cancers among Swedish patients with uveal mela-
noma but Callejo et al. [22] reported that in their Canadian 
cohort the statistical analysis showed no increased risk of 
a second cancer in patients with uveal melanoma.
That analysis showed that those patients’ education-
al level had a significant effect on the diagnosis and the 
presence of multiple primary cancers. Those who had 
Table 1. Characteristics of the study group
Gender Number of 
patients
Mean age Standard 
deviation
women 57 (58.8%) 61.6 9.8
men 40 (41.2%) 65.0 9.9
Total 97 63.2 9.9
Table 2. Characteristics of the control group
Gender Number of 
patients
Mean age Standard 
deviation
women 83 (58.0%) 59.3 11.8
men 60 (42.0%) 60.0 12.6
Total 143 59.6 12.1
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Fig. 1. Appearance of multiple primary cancers, depending on the 
occurrence of cancer among first degree relatives of patients
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Fig. 2. Appearance of multiple primary cancers, depending on the 
occurrence of cancer among those patients’ first and/or second de­
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higher education were represented in a greater number in 
the group of patients diagnosed with a second primary 
cancer. In that group, a significantly higher number of 
patients were classified (according to the ISCO-88 (COM) 
classification) as “professionals”. The result indicates how 
important the individual’s life and health history is when 
medical care based upon symptoms that may or may not 
suggest the presence of a cancer is sought. According to 
Tobiasz-Adamczyk, patients who have some disturbing 
signs suspect that grave illness because they have a prior 
knowledge of the telltale symptoms. Some patients, how-
ever, in spite of their knowledge of symptoms of cancer, 
may be incapable of proper diagnosis and evaluation of 
their condition. They may ignore or disregard the meaning 
of symptoms [23, 24].
Our analysis demonstrated that in the group of multi-
ple primary cancers participants were mostly residents of 
large cities, usually with a population of over 500 thou-
sand. That observation is probably associated with the in-
fluence of several factors. According to Tobiasz-Adamczyk, 
patients are more likely to seek medical attention when 
help is at hand [25]. Thus, easier access to medical insti-
tutions, services and state-of-art equipment and medical 
specialists may explain better detection of cancer among 
urban dwellers.
Availability of medical services is extremely important 
for patients who have uveal melanoma, because they have 
to be closely monitored for metastases. According to Eske-
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Fig. 3. Appearance of multiple primary cancers, depending on the 
level of education of patients
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lin et al., detecting metastases of uveal melanoma in pa-
tients (who have not reported any symptoms yet) may vary 
in the case of testing using abdominal ultrasound and as-
sessment of liver function (from the level of 59% for annual 
testing to over 95% in the case of semiannual testing [26]).
As for pregnancy, according to a literature review, hormon-
al changes significantly affect transformation of a choroidal 
naevus into a choroidal melanoma. In the group of 3,706 
patients examined by Shields et al. [27], pregnant women 
accounted for 0.4% of respondents (16 people). The authors 
observed that only in seven of those pregnant women did 
tumors that were previously considered to be stable start to 
proliferate. Based on that observation, it was suggested that 
perhaps immune tolerance to the fetus promotes a greater 
propensity for tumor development and a non-pregnant state 
may preclude exacerbation of the disease.
Romanowska-Dixon suggested that pregnancy appears 
to constitute a risk factor for the worsening of a pre-exist-
ing aberrancy [28].
In the analyzed material none of the 140 included wom-
en having a diagnosis of uveal melanoma were pregnant. 
The period between the last pregnancy and the time of be-
ing treated in the Cracow Clinic ranged from 9 to 52 years 
in the group with multiple primary cancers, and from 3 to 
57 years in the second group, with no identifiable primary 
cancer. Holly et al. [29], on the basis of their observations, 
found a correlation between decreased risk of uveal mela-
noma and increased parity.
Hartge et al. [30] observed an increased risk of uveal 
melanoma among women who had been pregnant or had 
previously had estrogen hormone replacement therapy. 
The risk decreased after surgical removal of the ovaries.
Among the patients analyzed, women with multiple 
primary cancers had significantly fewer pregnancies than 
patients who were not diagnosed with a second primary 
malignancy. That probably suggests a protective effect of 
pregnancy on the development of multiple cancers.
The described analysis was a retrospective chart review, 
not a prospective trial with clearly more rigorous reporting 
and data monitoring.
Conclusions
More common occurrence of malignant cancers in 1st 
and 1st and/or 2nd degree relatives of patients with uveal 
melanoma and other primary malignancies suggests ex-
istence of a common genetic factor in the development of 
different cancers.
A higher occurrence rate of multiple primary cancers 
among patients with better education and among patients 
working as “professionals” emphasizes the importance of 
knowledge of risk factors for development of a cancer, and 
of resulting more scrupulous observation of the primary 
neoplasm and more successful initiation of prophylactic 
interventions.
Persons living in cities (population > 500 K) are at high-
er risk for multiple primary cancers compared to those 
who live in rural areas. More frequent recognition of mul-
tiple primary cancers among persons living in cities (pop-
ulation > 500 K) may be associated with easier access to 
diagnosis, treatment, practitioners and equipment and 
with higher awareness of the role of pollution in the devel-
opment of malignant cancer.
Fewer pregnancies in the past among women with 
multiple primary cancers, compared to women without 
Table 3. Results of logistic regression
Constant Age Higher or 
secondary 
education 
Number of 
inhabitants over 
500 thousand
Number of 
surgeries
Cancers among 1st 
degree relatives
Assessment of the 
variable parameter
–6.434 0.026 1.171 1.384 3.840 0.584
Significance level of the 
parameter – p
0.000 0.097 0.000 0.004 0.000 0.087
Odds ratio (unit) 1.026 3.226 3.991 46.539 1.794
–95%CI 0.995 1.617 1.558 9.796 0.917
+95%CI 1.058 6.436 10.226 221.096 3.503
Table 4. Results of logistic regression.
Constant Age Higher or 
secondary 
education
Number of 
inhabitants over 
500 thousand
Number of 
surgeries
Cancers among 
1st/2nd  degree 
relatives
Assessment of the 
variable parameter
–6.717 0.030 1.133 1.342 3.762 0.716
Significance level of the 
parameter – p
0.000 0.058 0.001 0.006 0.000 0.039
Odds ratio (unit) 1.030 3.104 3.827 43.017 2.047
–95%CI 0.999 1.544 1.479 9.089 1.038
+95%CI 1.063 6.199 9.902 203.595 4.035
514 contemporary oncology
a second diagnosed primary malignancy, may suggest the 
protective effect of pregnancy against the development of 
multiple primary cancers.
The authors declare no conflict of interests.
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